Double blind group comparative study was done of 2% Sodium Cromoglycate solution four times a day and placebo in the management of perennial rhinitis in 45 patients. Duration of treatment was six weeks following a two week baseline. Five patients were excluded from the trial when they failed to return. Analysis of 20 patients in each group showed 8 patients (40%) in both treatment groups felt that the treatment made the symptoms completely or much better. The clinicians considered 13 patients (65%) in Sodium cromoglycate group and 11 patients (55%) in placebo group completely or much better. Statistically no significant difference was found between treatment groups for opinion of treatment, speed of onset of activity or acceptability of treatment. Improvement in symptoms assesed at the clinic were seen in both treatment groups.